-
Product Insights
Erectile Dysfunction – Drugs In Development, 2023
Global Markets Direct’s, ‘Erectile Dysfunction - Drugs In Development, 2023’, provides an overview of the Erectile Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Erectile Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tadalafil in Erectile Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tadalafil in Erectile Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tadalafil in Erectile Dysfunction Drug Details: Tadalafil (INT-0007) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BZ-371 in Erectile Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BZ-371 in Erectile Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BZ-371 in Erectile Dysfunction Drug Details: BZ-371 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BZ-371 in Erectile Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BZ-371 in Erectile Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BZ-371 in Erectile Dysfunction Drug Details: BZ-371 is under development for the...
-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Prostate Cancer
Overview How likely is it that the drugs in Metastatic Prostate Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Prostate Cancer Overview Metastatic prostate cancer occurs when cancerous cells...
-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)
Overview How likely is it that the drugs in Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Arterial Disease (PAD)/ Peripheral Vascular...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tadalafil in Erectile Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tadalafil in Erectile Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Tadalafil in Erectile DysfunctionDrug Details:Tadalafil (INT-0007) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Genistein in Pulmonary Radiation Toxicity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Genistein in Pulmonary Radiation Toxicity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genistein in Pulmonary Radiation Toxicity Drug Details: Genistein (BIO-300) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Genistein in Non-Small Cell Lung Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Genistein in Non-Small Cell Lung Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genistein in Non-Small Cell Lung Carcinoma Drug Details: Genistein (BIO-300)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sildenafil Citrate in Erectile Dysfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sildenafil Citrate in Erectile Dysfunction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sildenafil Citrate in Erectile Dysfunction Drug Details: Sildenafil citrate (ASP-001) is...